Pharmabiz8h
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...
Pharmabiz10h
Rusan Pharma’s chairman Dr Navin Saxena conferred with Russia’s prestigious ‘Order of Friendship’ and ‘Academic Honour’
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its chairman, Dr. Navin Saxena, ...
Pharmabiz18h
Pharmexcil invites member companies to supply API and raw material to Venezuela
Pharmexcil invites member companies to supply API and raw material to Venezuela: Shardul Nautiyal, Mumbai Friday, February 14, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Pro ...
Pharmabiz18h
India’s bio-economy to unleash its potential with robust bio-manufacturing infra, microbial bio-repository: Experts
Nandita Vijayasimha, Bengaluru Friday, February 14, 2025, 08:00 Hrs [IST] ...
Pharmabiz18h
Indian pharma exporters must unite and report challenges in exports to overcome trade barriers: Raja Bhanu
Indian pharma exporters must unite and report challenges in exports to overcome trade barriers: Raja Bhanu: Shardul Nautiyal, Mumbai Friday, February 14, 2025, 08:00 Hrs [IST] The ...
Pharmabiz18h
Earnings from JAKs grow 236 times in 10 years: Chemicals ministry
Chemicals ministry: Gireesh Babu, New Delhi Friday, February 14, 2025, 08:00 Hrs [IST] Earnings from the Jan Aushadhi Kendras (JAKs) ...
Pharmabiz10h
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...
Pharmabiz10h
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma: Shanghai Friday, February 14, 2025, 16:00 Hrs [IST] An ...
Pharmabiz9h
Tivic Health acquires exclusive global rights to TLR5 agonist Entolimod from Statera Biopharma to treat acute radiation syndrome
Fremont, California Friday, February 14, 2025, 17:00 Hrs [IST] ...
Pharmabiz18h
Budget allocation for SMDI doubles to Rs. 360 crore in FY26
The scheme for Strengthening of Medical Device Industry (SMDI), launched by the ministry of chemicals and fertilisers in November last year, is proposed to see the budget allocation doubling to Rs.
Pharmabiz11h
Santhera announces agreement with German GKV-SV on reimbursement for Agamree to treat Duchenne muscular dystrophy
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
Pharmabiz8h
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission: Vaduz, Liechtenstein Friday, February 14, 2025, 18:00 Hrs [IST] Implantica AG (publ.), a ...